Charles River Laboratories International (CRL) reported Q4 non-GAAP earnings Wednesday of $2.66 per diluted share, up from $2.46 per share a year earlier.
Analysts polled by FactSet expected $2.53.
Revenue for the quarter ended Dec. 28 was $1 billion, compared with $1.01 billion a year earlier.
Analysts surveyed by FactSet expected $983.6 million.
The company expects full-year 2025 non-GAAP earnings of $9.10 to $9.60 per share. Analysts surveyed by FactSet expect $9.60 per share. The company expects a revenue decrease for 2025 of 7% to 4.5%. Analysts polled by FactSet expect $3.87 billion.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。